KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Cash from Financing Activities (2016 - 2025)

Humana (HUM) has disclosed Cash from Financing Activities for 16 consecutive years, with -$168.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities changed N/A to -$168.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 billion, a N/A change, with the full-year FY2025 number at -$1.2 billion, up 51.15% from a year prior.
  • Cash from Financing Activities was -$168.0 million for Q4 2025 at Humana, up from -$603.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $3.3 billion in Q1 2023 to a low of -$2.4 billion in Q4 2022.
  • A 4-year average of $243.5 million and a median of -$144.0 million in 2021 define the central range for Cash from Financing Activities.
  • Biggest YoY gain for Cash from Financing Activities was 390.97% in 2022; the steepest drop was 231.18% in 2022.
  • Humana's Cash from Financing Activities stood at -$712.0 million in 2021, then tumbled by 231.18% to -$2.4 billion in 2022, then skyrocketed by 239.06% to $3.3 billion in 2023, then tumbled by 105.12% to -$168.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Cash from Financing Activities are -$168.0 million (Q4 2025), -$603.0 million (Q3 2025), and -$1.8 billion (Q2 2025).